🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of Bendamu...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-04-23
Trial ID
NCT00916058
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
Site Reference ID/Investigator# 17841
Start Date
2009-11
Trial ID
NCT00868413
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This was a single-arm, multicenter, Phase 2 study to evaluate the efficacy ...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2023-08-01
Trial ID
NCT05979948
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Pacific Oncololgy & Hematology
Start Date
2009-06
Trial ID
NCT00920855
Treatments Being Tested
TAC01-HER2 is a novel cell therapy that consists of genetically engineered ...
Status
Terminated
Location
Lurie Cancer Center - Northwestern University
Start Date
2021-04-19
Trial ID
NCT04727151
Treatments Being Tested
This open-label, international, multicenter study will investigate the safe...
Status
Completed
Location
Southern Cancer Center, PC
Start Date
2014-12-01
Trial ID
NCT02187861
Treatments Being Tested
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
This is a prospective, multicenter, single-arm, open phase II study to expl...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2024-08-31
Trial ID
NCT06554600
Treatments Being Tested